KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Invested Capital (2016 - 2026)

Amgen has reported Invested Capital over the past 18 years, most recently at $66.5 billion for Q1 2026.

  • For Q1 2026, Invested Capital rose 4.6% year-over-year to $66.5 billion; the TTM value through Mar 2026 reached $66.5 billion, up 4.6%, while the annual FY2025 figure was $63.3 billion, 4.11% down from the prior year.
  • Invested Capital for Q1 2026 was $66.5 billion at Amgen, up from $63.3 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $70.8 billion in Q4 2023 and troughed at $37.8 billion in Q1 2022.
  • A 5-year average of $60.5 billion and a median of $66.0 billion in 2024 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: fell 10.03% in 2022 and later soared 77.04% in 2023.
  • Year by year, Invested Capital stood at $42.6 billion in 2022, then soared by 66.46% to $70.8 billion in 2023, then dropped by 6.87% to $66.0 billion in 2024, then dropped by 4.11% to $63.3 billion in 2025, then increased by 5.14% to $66.5 billion in 2026.
  • Business Quant data shows Invested Capital for AMGN at $66.5 billion in Q1 2026, $63.3 billion in Q4 2025, and $64.2 billion in Q3 2025.